Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Vulvar Neoplasms 1Vulvar Diseases 1Vomiting 1Uterine Cervical Dysplasia 1Unspecified Adult Solid Tumor, Protocol Specific 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Seminoma 1Papillomavirus Infections 1Nausea 1Carcinoma in Situ 1

Interventions

Cisplatin 6Etoposide 4Carboplatin 4Bleomycin 4Radiotherapy 3sargramostim 2pegfilgrastim 2aldesleukin 2Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Ifosfamide 2Filgrastim 2lerisetron 1ixabepilone 1etoposide phosphate 1Vincristine 1Paclitaxel 1Levofloxacin 1Interferon-alpha 1Granisetron 1Fluorodeoxyglucose F18 1ER 30346 1Drug Therapy 1Dexamethasone 1Cyclophosphamide 1Arsenic Trioxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Testicular Germ Cell Tumor × Granisetron × Clear all
NCT00004219 2013-08-02

Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma

National Cancer Institute (NCI)

Phase 3 Unknown
150 enrolled
Genitourinary

Testicular Germ Cell Tumor, Nausea, Testicular Neoplasms, Vomiting, Seminoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡